The comprehensive review, now published in The Lancet, Diabetes & Endocrinology, highlights the need for dedicated services to optimise best practice diagnosis, care and healthcare outcomes in partnership with women. It also provides an up-to-date reference point for clinicians and other health professionals who provide healthcare to women with PCOS.
PCOS is a common condition that affects 8-13 per cent of women. Diagnosis is often delayed, requires multiple consultations and is based on irregular periods, higher levels or signs of excess male type hormones, including excessive hair growth or severe acne, and ultrasound changes on the ovaries. The condition has metabolic, psychological and reproductive features and is one of the main causes of infertility in women.
Professor Helena Teede, from the Monash Centre for Health Research and Implementation (MCHRI) says the review paves the way for the 2023 release of the International PCOS Guidelines, generously funded by the National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Women’s Health in Reproductive Life.
“There are key knowledge gaps that clinicians have when diagnosing and treating PCOS. The review seeks to improve accurate diagnosis, limit treatment inconsistencies and address barriers to providing patient-centered care. It also highlights the need for holistic models of care to support women and for greater investment in research in this common, yet complex condition,” said Professor Teede.
Professor Teede adds: “We’ve engaged extensively and listened to women with PCOS, many are frustrated with the delayed diagnosis and segregated management of their condition. To improve outcomes for women with PCOS, health professionals must be more knowledgeable and partner with women, focusing on what matters to them, as outlined in this important paper published today.”